HS Code 30021290 — Other antisera and blood fractions
Chapter 30 (Pharmaceutical Products) · Heading 3002 (Blood, antisera, vaccines, toxins, microorganisms and similar products) · Last updated: March 2026 · Source: Indian Customs (DGFT) Records
HS Code 30021290 (Other antisera and blood fractions) is one of India's most significant pharmaceutical export classifications under Chapter 30 of the Harmonized System. With a total trade value of $86.0B across 26,711 shipments, this code covers 54 distinct pharmaceutical products exported by 177 Indian manufacturers to 107 countries. The leading product under this classification is Serum at $83.8B, followed by Plasma and Device.
The top importing markets include United States, Nigeria, Russia. The top 5 products account for 99.9% of total trade under this code. Average transaction value is $3.2M. Leading exporters include NOVARTIS PHARMA AG and GLAXOSMITHKLINE BIOLOGICALS SA. Data sourced from Indian Customs (DGFT) shipping bill records.
Products Exported Under HS Code 30021290
54 pharmaceutical products classified under this code, ranked by trade value
| Rank | Product | Trade Value | Transactions | Avg Price | Suppliers |
|---|---|---|---|---|---|
| #1 | Serum | $83.8B | 3,990 | $3738.56 | 426 |
| #2 | Plasma | $1.1B | 2,250 | $2139.20 | 403 |
| #3 | Device | $651.0M | 211 | $10641.05 | 40 |
| #4 | Immunoglobulin | $254.7M | 1,214 | $6382.52 | 186 |
| #5 | Diagnostic | $92.9M | 3,032 | $50777.45 | 184 |
| #6 | Reagent | $78.2M | 6,711 | $6825.10 | 282 |
| #7 | Strip | $22.2M | 168 | $182.71 | 50 |
| #8 | Kit | $9.1M | 4,600 | $592.29 | 331 |
| #9 | Vitamin | $5.7M | 178 | $361.20 | 51 |
| #10 | Protein | $4.3M | 2,552 | $3548.63 | 245 |
| #11 | Ras | $2.5M | 358 | $975.42 | 66 |
| #12 | Sirolimus | $2.1M | 12 | $90.63 | 2 |
| #13 | Vaccine | $1.4M | 537 | $14.74 | 94 |
| #14 | Insulin | $552.7K | 113 | $10741069.01 | 25 |
| #15 | Nystatin | $232.0K | 2 | $39.38 | 2 |
Import Destinations — HS Code 30021290
107 countries import products classified under HS Code 30021290 from India
Indian pharmaceutical exports under HS Code 30021290 reach 107 countries worldwide. The largest importer is United States ($1.3B), followed by Nigeria ($374.9M), Russia ($117.3M), Sri Lanka ($114.5M). This geographic spread reflects India's position as the world's largest supplier of generic pharmaceutical products by volume.
| Rank | Country | Trade Value | Market Share |
|---|---|---|---|
| #1 | United States | $1.3B | 1.5% |
| #2 | Nigeria | $374.9M | 0.4% |
| #3 | Russia | $117.3M | 0.1% |
| #4 | Sri Lanka | $114.5M | 0.1% |
| #5 | Philippines | $101.4M | 0.1% |
| #6 | Pakistan | $95.7M | 0.1% |
| #7 | Bangladesh | $78.5M | 0.1% |
| #8 | Kenya | $76.4M | 0.1% |
| #9 | Netherlands | $66.5M | 0.1% |
| #10 | Indonesia | $63.1M | 0.1% |
| #11 | Turkey | $56.9M | 0.1% |
| #12 | Thailand | $55.0M | 0.1% |
| #13 | Saudi Arabia | $53.9M | 0.1% |
| #14 | Ethiopia | $53.1M | 0.1% |
| #15 | Singapore | $44.5M | 0.1% |
Top Indian Exporters — HS Code 30021290
177 Indian pharmaceutical manufacturers export under this classification
Understanding HS Code 30021290
The Harmonized System (HS) is an internationally standardized system of names and numbers to classify traded products, used by over 200 countries for customs tariffs and trade statistics. HS Code 30021290 is an 8-digit Indian Customs Tariff (ITC-HS) code that precisely identifies products classified as "Other antisera and blood fractions".
Code Structure Breakdown
The first 6 digits (300212) are standardized by the World Customs Organization (WCO) and used identically across all 200+ member countries. Digits 7-8 are India-specific subdivisions defined by the Directorate General of Foreign Trade (DGFT) for more granular classification of pharmaceutical exports. This code is declared on every shipping bill filed with Indian Customs for products matching this classification.
Regulatory & Compliance — HS Code 30021290
Correct classification under HS Code 30021290 is critical for customs clearance, duty assessment, and regulatory compliance. Misclassification can result in shipment delays, incorrect duty payments, and penalties from customs authorities.
Import Duty Rates
As a Chapter 30 pharmaceutical product, HS Code 30021290 may qualify for preferential duty rates in many markets. WTO TRIPS provisions and bilateral FTAs (e.g., India-ASEAN, India-Japan CEPA) can significantly reduce applicable duties.
DGFT Export Requirements
Indian exporters must declare HS Code 30021290 on shipping bills filed with DGFT. Pharmaceutical exports require Drug Controller General of India (DCGI) approval, Certificate of Pharmaceutical Product (COPP), and compliance with the Drugs & Cosmetics Act.
WHO Prequalification
Products under this code destined for international procurement programs (UNICEF, Global Fund, PEPFAR) typically require WHO Prequalification. PQ status affects eligibility for preferential procurement and duty exemptions in recipient countries.
Destination Country Registration
Each of the 107 importing countries has specific pharmaceutical registration requirements. Products must be registered with the national drug regulatory authority before customs clearance, regardless of HS code classification.
Need Shipment-Level Data for HS Code 30021290?
Access every individual shipping bill, supplier contacts, buyer details, and pricing trends for products classified under HS Code 30021290.
Shipment Records
26,711+ individual bills of lading
Verified Suppliers
177 exporters with contact details
Global Coverage
107 importing countries
Frequently Asked Questions — HS Code 30021290
Common questions about HS Code 30021290, answered with data from Indian Customs records.
What is HS code 30021290?
HS code 30021290 refers to "Other antisera and blood fractions" under Chapter 30 (Pharmaceutical Products), Heading 3002 (Blood, antisera, vaccines, toxins, microorganisms and similar products) of the Harmonized System. In India's export trade, this code covers $86.0B in trade value across 26,711 shipments from 177 exporters to 107 countries.
What products are exported under HS code 30021290?
54 distinct pharmaceutical products are exported from India under HS code 30021290. The top products include Serum ($83.8B), Plasma ($1.1B), Device ($651.0M). These cover a combined trade value of $86.0B.
Which countries import the most under HS code 30021290?
The top importing countries for HS code 30021290 from India are United States ($1.3B), Nigeria ($374.9M), Russia ($117.3M), Sri Lanka ($114.5M), Philippines ($101.4M). In total, Indian exporters ship products under this code to 107 countries worldwide.
Who are the top Indian exporters under HS code 30021290?
The leading Indian exporters under HS code 30021290 include NOVARTIS PHARMA AG ($2120.0B), GLAXOSMITHKLINE BIOLOGICALS SA ($254.0B), M/S. NOVO NORDISK A/S ($228.5B). In total, 177 Indian exporters ship products under this classification.
What is the import duty for HS code 30021290?
Import duties for HS code 30021290 (Other antisera and blood fractions) vary by destination country. As a Chapter 30 pharmaceutical product, many countries offer preferential or zero-duty rates for essential medicines under this code. The average transaction value from India is $3.2M, and importers should consult their national customs authority for applicable duty rates, exemptions, and regulatory requirements.
How is HS code 30021290 classified?
HS code 30021290 is an 8-digit Indian Customs Tariff (ITC-HS) code under Chapter 30 (Pharmaceutical Products), Heading 3002 (Blood, antisera, vaccines, toxins, microorganisms and similar products), Subheading 300212. The first 6 digits follow the international Harmonized System (WCO), while digits 7-8 are India-specific subdivisions used for customs and trade statistics.
What is the trade value of HS code 30021290 from India?
India's total export trade under HS code 30021290 is $86.0B across 26,711 shipments. The average shipment value is $3.2M. The largest product category is Serum at $83.8B.
Market Intelligence
Latest developments and market context
Detailed market intelligence for HS Code 30021290 — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
About This Data
Data Methodology
This analysis is compiled from Indian Customs (DGFT) shipping bill records covering the period 2020–2024. Each record includes the declared 8-digit ITC-HS code, product description, trade value (FOB USD), supplier name, buyer name, and destination country. Data is aggregated across all 54 pharmaceutical products classified under HS Code 30021290.
26,711
Shipment Records
54
Products
2020–2024
Data Coverage
Mar 2026
Last Updated
Disclaimer: Trade data is sourced from publicly available Indian Customs records. Values represent FOB (Free On Board) prices in USD. Actual import values may differ due to CIF adjustments, currency fluctuations, and destination country customs valuation methods.
Classification Details
Top Buyers
Top Importing Countries
Products Using This Code
Official References & Regulatory Resources
HS code classifications follow the WCO Harmonized System. Verify tariff rates with your national customs authority.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.HS Code Classification: HS Code 30021290 (Other antisera and blood fractions) identified under Chapter 30 (Pharmaceutical Products), Heading 3002.
- 2.Product Categorization: 54 pharmaceutical products mapped to this HS code using DGFT product description matching and Indian Customs tariff classification.
- 3.Trade Value Aggregation: Total trade value of $86.0B aggregated from 26,711 individual shipping bill records across 177 exporters.
- 4.Country Breakdown: Exports distributed across 107 destination countries, with market share calculated per country based on FOB values.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
54 Products Under This Code
177 exporters to 107 countries
Expert-Reviewed
By pharmaceutical trade specialists
Enterprise Trade Intelligence
Unlock shipment-level data, supplier contacts, and custom reports for HS Code 30021290.
Request Demo